A team led by researchers at Weill Cornell Medicine, the University of Wisconsin-Madison; Scripps Research and the University of Chicago has identified an antibody that appears to block infection by all dominantvariants of the virus that causes COVID-19, including Omicron, the most recent. Their discovery could lead to more potent vaccines and new antibody-based treatments.
In a study published March 6 in the Journal of Clinical Investigation, senior author Dr. Patrick Wilson, the Anne E...
Read More
Recent Comments